WHO ICTRP trial

A pilot study to determine the feasibility and acceptability of a…

ACTRN12617001070325 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12617001070325
Public title A pilot study to determine the feasibility and acceptability of a non-pharmacological intervention to prevent delirium for people with advanced cancer in hospital.
Scientific title Phase 2 cluster randomized controlled trial of a multi-component non-pharmacological intervention to prevent delirium for hospitalized people with advanced cancer: The PRESERVE pilot study.
Primary sponsor The Palliative Care Clinical Studies Collaborative (PaCCSC)
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Delirium;Advanced cancer; Delirium Advanced cancer;Neurological - Other neurological disorders;Cancer - Any cancer
Interventions Routine delirium screening and diagnostic assessment and a multi-component non-pharmacological delirium prevention intervention will be implemented in four oncology/palliative care inpatient units. Bedside nurses will complete the Nursing…
Registration date Jul 24, 2017
Target size 40
Secondary IDs Nil known
Registry page anzctr.org.au

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations